|
Erythropoietin administration is associated with improved T-cell properties in patients with myelodysplastic syndromes
|
Nov 2016
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Flow cytometry to distinguish myelodysplastic syndromes from non-neoplastic causes of cytopenia: Ready for prime time?
|
Jun 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
The role of T-cells in the pathogenesis of myelodysplastic syndromes: Passengers and drivers
|
Dec 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Involvement of deleted chromosome 5 in complex chromosomal aberrations in newly diagnosed myelodysplastic syndromes (MDS) is correlated with extremely adverse prognosis
|
Feb 2014
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases
|
Mar 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Variations in erythropoiesis-stimulating agent administration in transfusion-dependent myelodysplastic syndromes impact response
|
Mar 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Low efficacy and high mortality associated with clofarabine treatment of relapsed/refractory acute myeloid leukemia and myelodysplastic syndromes
|
Feb 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Historical perspectives on myelodysplastic syndromes
|
Aug 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Early treatment initiation in lower-risk myelodysplastic syndromes produces an earlier and higher rate of transfusion independence
|
Aug 2017
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Aplastic Anemia and MDS International Foundation (AAMDSIF): Bone marrow failure disease scientific symposium 2016
|
Nov 2016
|
Leuk Res
|
aplastic anemia
|
